These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34334412)

  • 1. The Safety Factor for Neuromuscular Transmission: Effects of Dimethylsulphoxide, Cannabinoids and Synaptic Homeostasis.
    Odierna GL; Phillips WD
    J Neuromuscul Dis; 2021; 8(5):831-844. PubMed ID: 34334412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evoked responses in normal and diseased muscle with particular reference to twitch potentiation.
    Krarup C
    Acta Neurol Scand; 1983 Nov; 68(5):269-315. PubMed ID: 6320576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M; Sakato S; Okumura S
    J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of myasthenic immunoglobulin G on neuromuscular transmission in mouse diaphragm.
    Chiu HC; Chen ML; Tsai MC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):217-23. PubMed ID: 2827968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
    Pagala MK; Tada S; Namba T; Grob D
    Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacological study of the effect of carbamazepine on neuromuscular transmission in the rat diaphragm.
    Tsai MC
    Neuropharmacology; 1985 Apr; 24(4):345-51. PubMed ID: 2987729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides isolated from the venom of Conus geographus block neuromuscular transmission.
    McManus OB; Musick JR; Gonzalez C
    Neurosci Lett; 1981 Aug; 25(1):57-62. PubMed ID: 6269031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
    Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
    Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission.
    Morsch M; Protti DA; Cheng D; Braet F; Chung RS; Reddel SW; Phillips WD
    Sci Rep; 2018 Mar; 8(1):4685. PubMed ID: 29549349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low quantal content of the endplate potential reduces safety factor for neuromuscular transmission in the diaphragm of the newborn rat.
    Wareham AC; Morton RH; Meakin GH
    Br J Anaesth; 1994 Feb; 72(2):205-9. PubMed ID: 8110574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular synapse electrophysiology in myasthenia gravis animal models.
    Plomp JJ; Huijbers MGM; Verschuuren JJGM
    Ann N Y Acad Sci; 2018 Jan; 1412(1):146-153. PubMed ID: 29068559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
    Lambert EH; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():300-18. PubMed ID: 1066990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of (+)-tubocurarine on neuromuscular facilitation and depression in rat diaphragm.
    Hinman DJ; Jacobs RS; Karczmar AG
    Neuropharmacology; 1976 Jul; 15(7):427-32. PubMed ID: 185539
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of myasthenic IgG on miniature end-plate currents in mouse diaphragm.
    Pennefather P; Quastel DM
    Life Sci; 1980 Dec; 27(22):2047-54. PubMed ID: 7207007
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.